Page 6 - Biotronik_Multi BENE Study

Basic HTML Version

Primary endpoint
Target vessel failure (TVF) at 6 months
··
Secondary endpoints
Major adverse cardiac events (MACE) at 1, 6 and 12 months
··
Target vessel revascularisation (TVR) at 1, 6 and 12 months
··
Target lesion revascularisation (TLR) at 1, 6 and 12 months
··
Device, procedure and lesion success
··
Secondary endpoints for angiographic subgroup
Late lumen loss (LLL), binary angiographic in-stent and in-segment restenosis at 6 months
··
Endpoints